Epidemiological evidence for an association between use of wireless phones and tumor diseases
- PMID: 19268551
- DOI: 10.1016/j.pathophys.2009.01.003
Epidemiological evidence for an association between use of wireless phones and tumor diseases
Abstract
During recent years there has been increasing public concern on potential cancer risks from microwave emissions from wireless phones. We evaluated the scientific evidence for long-term mobile phone use and the association with certain tumors in case-control studies, mostly from the Hardell group in Sweden and the Interphone study group. Regarding brain tumors the meta-analysis yielded for glioma odds ratio (OR)=1.0, 95% confidence interval (CI)=0.9-1.1. OR increased to 1.3, 95% CI=1.1-1.6 with 10 year latency period, with highest risk for ipsilateral exposure (same side as the tumor localisation), OR=1.9, 95% CI=1.4-2.4, lower for contralateral exposure (opposite side) OR=1.2, 95% CI=0.9-1.7. Regarding acoustic neuroma OR=1.0, 95% CI=0.8-1.1 was calculated increasing to OR=1.3, 95% CI=0.97-1.9 with 10 year latency period. For ipsilateral exposure OR=1.6, 95% CI=1.1-2.4, and for contralateral exposure OR=1.2, 95% CI=0.8-1.9 were found. Regarding meningioma no consistent pattern of an increased risk was found. Concerning age, highest risk was found in the age group <20 years at time of first use of wireless phones in the studies from the Hardell group. For salivary gland tumors, non-Hodgkin lymphoma and testicular cancer no consistent pattern of an association with use of wireless phones was found. One study on uveal melanoma yielded for probable/certain mobile phone use OR=4.2, 95% CI=1.2-14.5. One study on intratemporal facial nerve tumor was not possible to evaluate due to methodological shortcomings. In summary our review yielded a consistent pattern of an increased risk for glioma and acoustic neuroma after >10 year mobile phone use. We conclude that current standard for exposure to microwaves during mobile phone use is not safe for long-term exposure and needs to be revised.
Similar articles
-
Use of mobile phones and cordless phones is associated with increased risk for glioma and acoustic neuroma.Pathophysiology. 2013 Apr;20(2):85-110. doi: 10.1016/j.pathophys.2012.11.001. Epub 2012 Dec 21. Pathophysiology. 2013. PMID: 23261330
-
Mobile phones, cordless phones and the risk for brain tumours.Int J Oncol. 2009 Jul;35(1):5-17. doi: 10.3892/ijo_00000307. Int J Oncol. 2009. PMID: 19513546
-
Case-control study of the association between malignant brain tumours diagnosed between 2007 and 2009 and mobile and cordless phone use.Int J Oncol. 2013 Dec;43(6):1833-45. doi: 10.3892/ijo.2013.2111. Epub 2013 Sep 24. Int J Oncol. 2013. PMID: 24064953 Free PMC article.
-
Cell phone use and acoustic neuroma: the need for standardized questionnaires and access to industry data.Surg Neurol. 2009 Sep;72(3):216-22; discussion 222. doi: 10.1016/j.surneu.2009.01.010. Epub 2009 Mar 27. Surg Neurol. 2009. PMID: 19328527 Review.
-
Long-term use of cellular phones and brain tumours: increased risk associated with use for > or =10 years.Occup Environ Med. 2007 Sep;64(9):626-32. doi: 10.1136/oem.2006.029751. Epub 2007 Apr 4. Occup Environ Med. 2007. PMID: 17409179 Free PMC article. Review.
Cited by
-
Human‑made electromagnetic fields: Ion forced‑oscillation and voltage‑gated ion channel dysfunction, oxidative stress and DNA damage (Review).Int J Oncol. 2021 Nov;59(5):92. doi: 10.3892/ijo.2021.5272. Epub 2021 Oct 7. Int J Oncol. 2021. PMID: 34617575 Free PMC article. Review.
-
Transcriptomic Profile Reveals Deregulation of Hearing-Loss Related Genes in Vestibular Schwannoma Cells Following Electromagnetic Field Exposure.Cells. 2021 Jul 20;10(7):1840. doi: 10.3390/cells10071840. Cells. 2021. PMID: 34360009 Free PMC article.
-
Development of health-based exposure limits for radiofrequency radiation from wireless devices using a benchmark dose approach.Environ Health. 2021 Jul 17;20(1):84. doi: 10.1186/s12940-021-00768-1. Environ Health. 2021. PMID: 34273995 Free PMC article.
-
Vestibular Schwannoma: What We Know and Where We are Heading.Head Neck Pathol. 2020 Dec;14(4):1058-1066. doi: 10.1007/s12105-020-01155-x. Epub 2020 Mar 30. Head Neck Pathol. 2020. PMID: 32232723 Free PMC article. Review.
-
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.Drug Deliv. 2019 Dec;26(1):551-565. doi: 10.1080/10717544.2019.1616235. Drug Deliv. 2019. PMID: 31928355 Free PMC article. Review.
LinkOut - more resources
Full Text Sources